MedPacto is leading combination trials in collaboration with world-renowned institutions and global pharmaceutical companies such as Merck and AstraZeneca.
Partnering Opportunities
01
with innovative technology for the therapeutic areas that are of interest
- institutes, pharma, biotech
02
Hospitals and organizations with strong specialization in targeted indications
03
Large pharma with a proven track record of strong clinical development and commercialization abilities
